News

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
The FDA has expanded the approval of Dextenza (dexamethasone ophthalmic insert) to include pediatric treatment.
Dextenza is an intracanalicular insert that delivers a 0.4mg dose of dexamethasone, a corticosteroid, for up to 30 days following insertion.
You know that little pink part in the inside corner of your eyeball, right next to the bridge of your nose? It's the kind of ...
Fitzpatrick skin type influences both characteristics and outcomes associated with uveal melanoma and conjunctival melanoma.
Apr. 3, 2025 — A new CT-scan based risk score facilitates the identification of patients at risk of revision endoscopic sinus surgery due to chronic ...